2 completed. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
Follow NMIBC: new trials by email Literature Review of NMIBC trials Research Report on NMIBC
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase I-II Study of Novel Oncolytic Virus VG161 Via Intravesical Instillation for BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer VG161 via Intravesical Instillation - NMIBC | Phase 1 / Phase 2 | Completed | Ding-Wei Ye | 20 | 2021-10-12 | 2026-04-01 |
| A Study of Pemigatinib in Non-muscle Invasive Bladder Cancer Patients With Recurrent Low- or Intermediate-Risk Tumors Pemigatinib - Bladder Cancer, NMIBC | Phase 2 | Completed | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 30 | 2020-10-02 | 2025-10-03 |
Non-Muscle Invasive Bladder Neoplasms (2) · Carcinoma, Transitional Cell (1) · Urinary Bladder Neoplasms (1)
Carcinoma (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Male Urogenital Diseases (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms by Site (2) · Neoplasms, Glandular and Epithelial (2) · Urinary Bladder Diseases (2) · Urogenital Diseases (2) · Urogenital Neoplasms (2) · Urologic Diseases (2) · Urologic Neoplasms (2) · Urinary Bladder Neoplasms (1)
pemigatinib (1)
Ding-Wei Ye (1) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (1)
China (1) · United States (1)
Noah M Hahn, MD (1)